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This is one paper in a three-part series that
sets out how evidence should be translated
into guidance to inform policies on health
systems and improve the delivery of clinical
and public health interventions.
Introduction
Health systems interventions establish or
modify governance (e.g., licensing of pro-
fessionals), financial (e.g., health insurance
mechanisms) and delivery (e.g., by whom
care is provided) arrangements, and imple-
mentation strategies (e.g., strategies to
change health provider behaviours) within
health systems (which consist of ‘‘all
organisations, people and actions whose
primary intent is to promote, restore or
maintain health’’; see Box S1 for definitions
of the terms used in this article). The focus
oftheseinterventionsistostrengthenhealth
systems in their own right or to get cost-
effective programmes and technologies
(e.g., drugs and vaccines) to those who
need them. Decisions regarding health
systems strengthening, including the devel-
opment of recommendations by policy
makers, require evidence on the effective-
ness of these interventions, as well as many
other forms of evidence. For example, in
assessing potential policy options, reviews
of economic evaluations and of qualitative
studies of stakeholders’ views regarding
these options might be important (Table
S1). Such evidence helps to address ques-
tions such as the cost-effectiveness of these
options and which options are seen as
appropriate by stakeholders.
Assessing how much confidence to place
in the types of evidence available on health
systems interventions is a key component
in informing judgements regarding the use
of such interventions for health systems
strengthening (Box 1). This paper, which is
the third of a three-part series on health
systems guidance [1,2], aims to:
N Illustrate a range of tools available to
assess the different types of evidence
needed to support different steps in the
policy-making process;
N Discuss the GRADE (Grading of
Recommendations Assessment, Devel-
opment and Evaluation) approach to
assessing confidence in estimates of
effects (‘‘quality of evidence’’) and to
grading the strength of recommenda-
tions on policy options for health
systems interventions;
N Discuss factors that are important
when developing recommendations
on policy options regarding health
systems interventions.
The Policy Forum allows health policy makers
around the world to discuss challenges and
opportunities for improving health care in their
societies.
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PLoS Medicine | www.plosmedicine.org 1 March 2012 | Volume 9 | Issue 3 | e1001187The first paper in this series makes a
case for developing guidance to inform
decisions on health systems questions and
explores challenges in producing such
guidance and how these might be ad-
dressed [1]. The second paper explores the
links between guidance development and
policy development at global and national
levels, and examines the range of factors
that can influence policy development [2].
In this paper, which like the other two
papers is based on discussions of the Task
Force on Developing Health Systems
Guidance (Box 2; [1,2]), we focus partic-
ularly on the GRADE approach, which
provides a transparent and systematic
approach to rating the quality of evidence
and grading the strength of recommenda-
tions [3].
Tools to Assess the Evidence
Needed to Support the Policy-
Making Process for Health
Systems Strengthening
Well-conducted systematic reviews [4]
can be used to identify the best available
evidence to inform judgements about the
effects of policy options and to inform
other key steps within the policy-making
process (Table S1). As discussed in the
second paper of this series [2], users need
to be able to assess the quality of evidence
presented in such reviews in relation to
each step of the policy-making process.
For example, when defining the problem
and the need for intervention, tools are
required to assess the confidence we can
place in evidence from reviews of studies
highlighting different ways of conceptual-
ising the problem (e.g., reviews of studies
of people’s experiences of the problem)
[5]. When assessing potential policy op-
tions, tools are needed to assess the
confidence that can be placed in, for
example, studies assessing impact (e.g.,
reviews of effectiveness studies). Similarly,
when identifying implementation consid-
erations, tools are required to assess the
confidence that can be placed in reviews of
factors affecting implementation.
Many tools are available to assess the
risk of bias in individual studies of the
effects of interventions [6] and to appraise
individual qualitative studies [7]. Tools are
also available to assess the quality of
evidence synthesised in systematic reviews
[6]. Such tools need to be appropriate to
the types of studies included in the review
and generic enough to be applicable across
a range of questions, and must allow
meaningful conclusions to be drawn re-
garding the quality of the included evi-
dence. Judgements on how much confi-
dence can be placed in the evidence from
a review need to be distinguished from
judgements about how well the review was
conducted (i.e., its reliability). Tools have
been developed to assess the reporting of
systematic reviews and meta-analyses (e.g.,
the PRISMA checklist [8]) and to assess
their methodological quality or reliability
(e.g., the SUPPORT tools [9] and AM-
STAR [10]) (Table 1). However, we focus
here on tools to assess how much confi-
dence can be placed in the evidence
identified and presented in those reviews.
Assessing How Much Confidence to
Place in the Findings of Reviews of
the Effects of Policy Options
Tools to assess how much confidence to
place in review findings are most devel-
Summary Points
N Assessing how much confidence to place in different types of research evidence
is key to informing judgements regarding policy options to address health
systems problems.
N Systematic and transparent approaches to such assessments are particularly
important given the complexity of many health systems interventions.
N Useful tools are available to assess how much confidence to place in the
different types of research evidence needed to support different steps in the
policy-making process; those for assessing evidence of effectiveness are most
developed.
N Tools need to be developed to assist judgements regarding evidence from
systematic reviews on other key factors such as the acceptability of policy
options to stakeholders, implementation feasibility, and equity.
N Research is also needed on ways to develop, structure, and present policy
options within global health systems guidance.
N This is the third paper in a three-part series in PLoS Medicine on health systems
guidance.
Box 1. Reasons Why It Is Important to Assess How Much
Confidence Can Be Placed in Evidence to Guide Decisions on
Health Systems Strengthening
N Users of such evidence almost always draw implicit or explicit conclusions
regarding how much confidence to place in evidence
N Such evidence may inform judgements regarding recommendations, including
the strength of such recommendations
N Systematic and explicit approaches can be useful in:
N facilitating critical appraisal of evidence
N protecting against bias
N clarifying implementation issues
N resolving disagreements among stakeholders
N communicating information regarding the evidence, the judgements made,
and recommendations drawn from it
N Systematic and explicit approaches are particularly important given the
complexity of many health systems interventions. These interventions may be
complex in terms of the number of discrete, active components and the
interactions between them; the number of behaviours to which the
intervention is directed; the number of organisational levels targeted by the
intervention; the degree of flexibility or tailoring permitted in intervention
implementation; the level of skill required by those delivering the intervention;
and the extent of context dependency [48,49]. Given the complexity of these
interventions, deciding on the contextual relevance of evidence is a crucial
component.
Source: adapted from [30].
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effectiveness. The GRADE approach is
one such tool, but many others are
available [11]. Within GRADE, the qual-
ity of evidence derived from a systematic
review is related to the quality of the
included studies and to a range of other
factors (Table S2). This approach has
many strengths (Table S3) and is now
used increasingly by international organi-
zations, including the World Health Or-
ganization (WHO), the Cochrane Collab-
oration, and several agencies developing
guidelines [3]. (Also see http://www.
gradeworkinggroup.org.) We will discuss
the application of the GRADE approach
to assess the quality of evidence and the
strength of recommendations for health
systems interventions later.
Assessing How Much Confidence to
Place in the Findings of Reviews of
Questions Other Than Effects
Tools to assist judgements on how much
confidence to place in the findings of
reviews of questions other than effects that
are relevant to the policy-making process
are at an early stage of development. Such
questions include stakeholders’ values and
preferences and the feasibility of interven-
tions (Table S1). For some of these issues,
judgements might be informed by system-
atic reviews of qualitative studies, together
with local evidence [12]. Where reviews
seek a qualitative answer to understand
the nature of a problem, quality appraisal
aims to assess the coherence of the
resulting explanation, possibly across dif-
ferent contexts. Although quality criteria
for individual qualitative research studies
commonly consider the methods of each
study and the credibility and richness of
their findings [7,13,14], thus far tools for
assessing the quality of systematic reviews
of qualitative research have not considered
the credibility and richness of findings. A
potential tool for doing this is proposed in
Table S4.
Reviews exploring factors affecting the
implementation of options might employ
mixed methods syntheses (i.e., syntheses of
both qualitative and quantitative evidence)
such as realist synthesis [15], which
explores the explanatory theories implicit
in existing programmes or policies, or
framework synthesis, which provides a
highly structured, deductive approach to
data analysis drawing on an existing model
or framework (for example, [16–18]).
Quality appraisal then focuses on the
confidence that can be placed in each
conclusion drawn from individual studies
[19]. Grading the evidence as a whole can
take into account the number and context
of the studies contributing to each conclu-
sion, and the appropriateness of their
methods for drawing that conclusion (for
illustration, see [16]). A single study might
refute or qualify a theory, but multiple
studies together contribute to strengthen-
ing a theory. As yet, there are no tools for
appraising how well mixed methods re-
Box 2. The Task Force on Developing Health Systems Guidance
N The Task Force on Developing Health Systems Guidance was established in
2009 by the World Health Organization (WHO) to improve its response to
requests for guidance on health systems.
N The Task Force consisted of 20 members selected by WHO for their expertise in
the field of health systems research and implementation.
N Through a series of face-to-face and virtual meetings, the Task Force provided
input to and oversight of the development of a Handbook for Developing Health
Systems Guidance and to the identification of broader issues that warranted
further dialogue and debate [39].
N As part of this process, the Task Force and the Handbook developers reviewed
approaches to developing clinical guidelines and the instruments used for
clinical guideline development.
N The Task Force suggested ways in which some of these approaches and
instruments could be adapted for use in the development of health systems
guidance and indicated where there were important differences between these
approaches.
N The writing group for this paper further considered the issues raised in these
discussions and produced a first draft of the manuscript for comment by the
Task Force.
N This paper, and the other two in the series [1,2], were finalised after several
iterations of comments by the Task Force and external reviewers.
Table 1. Commonly used tools to assess systematic reviews and their findings and to assess clinical guidelines.
Systematic Reviews
SUPPORT (SUPporting Policy Relevant Reviews and Trials) tool [9] A tool to assess how much confidence to place in the methodological quality of
a systematic review, and designed for reviews of health systems interventions
AMSTAR (A measurement tool for the ‘‘assessment
of multiple systematic reviews’’) [10]
A tool designed to assess the methodological quality of a systematic review. This
tool has not been designed specifically to assess how much confidence to place
in reviews of health systems interventions
GRADE (Grading of Recommendations Assessment,
Development and Evaluation) [41]
An approach to assess the quality of evidence
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analyses) [8] A tool to assess the reporting of systematic reviews and meta-analyses
SUPPORT applicability tool [33] and Wang applicability
and transferability tool [34]
Tools to assist in assessing the applicability of the findings of a systematic review
to a specific setting
Guidelines
AGREE (Appraisal of Guidelines for Research and Evaluation) [42] A tool to evaluate the process of practice guideline development and the quality
of reporting
GRADE [41] An approach to grade the strength of recommendations
doi:10.1371/journal.pmed.1001187.t001
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conclusions about the advantages or
disadvantages of policy options.
Resource use is another key issue, and
tools are available to assess the reliability
of reviews of economic studies [20]. In
addition, GRADE provides guidance on
how to incorporate considerations of
resource use into recommendations [21].
The GRADE Approach to
Assessing Confidence in the
Estimates of Effects for
Health Systems Interventions
The GRADE approach clearly sepa-
rates two issues: the quality of the evidence
and the strength of recommendations.
Quality of evidence is only one of several
factors considered when assessing the
strength of recommendations.
Within the context of a systematic
review, GRADE defines the quality of
evidence as the extent to which one can be
confident in the estimate of effect. Within
the context of guidelines or guidance,
GRADE defines the quality of evidence
as the confidence that the effect estimate
supports a particular recommendation.
The degree of confidence is a continuum
but, for practical purposes, it is categorised
into high, moderate, low, and very low
quality (Table S5).
Evidence on the effectiveness of health
systems interventions raises a number of
challenges that may, in turn, influence
assessments of the quality of this evidence
and the development of recommendations
using the GRADE approach. Firstly, while
experimental studies (including pragmatic
randomised trials [22]) are feasible for
some health systems interventions, for
others (particularly those related to gover-
nance and financial arrangements), evi-
dence may come mainly from observa-
tional studies, including evaluations of
national or state-wide programmes
[23,24]. Secondly, evaluations of health
systems interventions often use clustered
designs and these are frequently poorly
conducted, analysed, and reported
[25,26]. Thirdly, health systems interven-
tions tend to measure proxy outcomes,
such as the use of services or the uptake of
an incentive. Evidence users need to
decide whether there is sufficiently strong
evidence of a relationship between the
proxy outcome and the desired health
outcome. The development of an out-
comes framework to assist in assessing
interventions (for an example, see [27,28])
may help those developing guidance
decide whether proxy outcomes are suffi-
cient. Finally, poorly described health
systems and political systems factors and
implementation considerations may make
it difficult to develop contextualised rec-
ommendations on policy options [29].
GRADE attempts to make the judgements
regarding these issues systematic and
transparent.
Developing Recommendations
on Policy Options for
Consideration Regarding
Health Systems Interventions
Moving from evidence to recommenda-
tions on options for consideration often
necessitates the interpretation of factors
other than evidence. In most cases, these
interpretations require judgments, making
it important to be transparent, particularly
given that recommendations will some-
times need to consider multiple complex
health systems interventions, each with its
own assessment of quality of evidence.
Another challenge is the additional com-
plexity of assessing the wide range of
health system and political system factors
that will influence the choice and imple-
mentation of options for addressing a
health system problem in different settings
(see the other papers in this series [1,2]).
For example, a health systems problem
may involve a wide range of stakeholders,
each with views regarding the available
options. In addition, health systems inter-
ventions may have system-wide effects that
vary across settings. Consequently, rather
than making a single recommendation as
in clinical guidelines, it may be more
useful for health systems guidance to set
out the evidence and outline a range of
options, appropriate to different settings,
to address a given health systems problem.
These options may, in turn, feed into
deliberative or decision-making processes
at national or sub-national levels, as
discussed later and elsewhere in this series
[2].
Tools such as GRADE assist in grading
the strength of a recommendation regard-
ing options [30,31] and can be applied to
health systems interventions, but may
benefit from explicitly including some
additional factors (Box 3). Further re-
search is needed to explore the usefulness
of these additional factors but, in general,
any tool used to guide the development of
recommendations should aim to improve
transparency by explicitly describing the
factors, and their interpretation, that
contributed to the development of recom-
mendations.
Within the GRADE approach, recom-
mendations reflect the degree of confi-
dence that the desirable effects of applying
a recommendation outweigh the undesir-
able effects. Specifically, a strong recom-
mendation implies confidence that the
desirable effects of applying a recommen-
dation outweigh the undesirable effects,
whereas a conditional/qualified/weak rec-
ommendation suggests that the desirable
effects of applying a recommendation
probably outweigh the undesirable effects,
but there is uncertainty.
GRADE attempts to make all judg-
ments regarding the factors that are
considered in developing recommenda-
tions transparent (by documenting these
judgments) and systematic (by using the
same approach across all the questions
being considered by the guideline).
Tables 2, S6, and S7 provide illustrations
of the application of the GRADE ap-
proach to health systems interventions
involving delivery and financial arrange-
ments and implementation strategies, re-
spectively, and show how guidance on
health systems interventions might outline
a range of options appropriate to different
settings—an approach on which further
research is needed. In common with other
grading systems, GRADE does not yet
provide guidance on how to assess the
level of confidence that can be placed in
evidence on ‘‘acceptability’’ or ‘‘feasibili-
ty’’. Conventionally, these judgements
have been made by consensus among the
guideline panel, which needs to include
individuals with expertise and experience
relevant to the guideline questions. Fur-
ther work is needed to develop a formal
way of assessing the quality of such
evidence.
Challenges in Moving from an
Assessment of the Quality of
Evidence to Making
Recommendations on Policy
Options
The move from an assessment of the
quality of evidence to making recommen-
dations on policy options involves a
number of challenges. Firstly, assessments
of the strength of a recommendation may
require a detailed understanding of the
evidence creation and evaluation process
that is not always available. Secondly,
categorising recommendations as ‘‘strong’’
and ‘‘weak’’ can raise difficulties. Panels
developing global guidance may, for
example, be reluctant to make ‘‘weak’’
recommendations in case policy makers
fail to respond to such recommendations
because they assume they are equivalent to
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ity of evidence is typically assessed for two
alternative policy options in tools such as
GRADE, while many health system (and,
indeed, many clinical decisions) involve
multiple interventions, which adds to the
complexity of interpretation and decision-
making and makes it even more important
to be transparent.
How might some of these challenges be
addressed? Methodological expertise is
needed to conduct and interpret system-
atic reviews and perform assessments using
tools such as GRADE. Health systems
guidance panels therefore need to be
supported by methodology experts. More-
over, the outputs of these tools need to be
‘‘translated’’ into appropriate language
and formats to ensure that they can be
interpreted and used correctly by the
panel. Research is under way within
initiatives such as the DECIDE (Develop-
ing and Evaluating Communication strat-
egies to support Informed Decisions and
practice based on Evidence; http://www.
decide-collaboration.eu) collaboration on
ways of presenting information on
GRADE assessments and policy options
to policy makers.
Additional Challenges
There are other wider challenges in-
volved in making recommendations on
policy options regarding health systems
interventions. Firstly, the tools used to
assess the quality of evidence and develop
recommendations need to be able to
accommodate the wide range of study
designs that is used to assess the effective-
ness of health system interventions. This is
possible within GRADE. Secondly, tools
need to be developed to inform judge-
ments on how much confidence to place in
the other forms of evidence (e.g., evidence
on acceptability) that are needed to
develop recommendations regarding
health systems interventions [32].
Finally, international standard-setting
organisations, such as WHO, have to
formulate recommendations that are appli-
cable at a global level. However, as noted
earlier, creating global recommendations
on health systems questions can be difficult
because of important variations in context-
specific factors that influence the applica-
bility of interventions at national and sub-
national levels [2,33]. An approach that
should help to link guidance development
at the global level with policy development
at the national level is outlined in the
second paper of this series [2].
Where it is useful to make recommen-
dations at the global level, those develop-
ing guidance may choose to outline policy
options rather than a single recommenda-
tion. Such options may encompass one or
more questions and may be based on the
range of interventions considered in rela-
tion to these questions. Health and political
systems factors could be taken into account
by linking specific options to these factors.
For example, the options may describe
variations in the intervention content and
method of implementation, based on the
evaluations that have been conducted in
different settings. Further work is needed to
explore how policy makers might interpret
and select policy options outlined in global
guidance. However, one useful approach
might be to provide national decision
makers with tools to assist them in making
recommendations appropriate to their set-
ting. Several suchtools are available [33,34]
or in development (see http://www.decide-
collaboration.eu/work-packages-strategies).
Importantly, global guidance should always
indicate the factors that should be consid-
ered to assess the implications of variations
in intervention, context, and other condi-
tions. Decision models may be useful in
exploring the effects of these variations (for
example, [35,36]). Given the often low
quality evidence available regarding policy
options for health systems problems, it is
also likely that in many cases the recom-
mended option(s) will need to be evaluated.
Presenting Evidence Regarding
Contextual and Implementation
Issues to Guidance Panels and Policy
Makers
The best way to communicate evidence
on contextual and implementation issues
related to health systems and political
systems to guidance panels and policy
makers to inform their judgements about
the strength of recommended options is
currently unclear. Related work on sum-
mary of findings tables for systematic
reviews of effects and evidence summaries
for policy makers has illustrated the
importance of paying attention to both
format and content in developing useful
and understandable presentation ap-
proaches [37,38]. The Handbook for Devel-
oping Health Systems Guidance sets out an
approach for presenting this type of
evidence to stakeholders in a user-friendly
evidence profile [39]. Similarly, the second
paper in this series describes the wider
features of health and political systems that
may need to be assessed to inform
decision-making [2].
If we want to ensure that guidance
panels and policy makers use evidence to
inform judgements about the strength of
recommended options, more research is
needed to develop and test approaches
(including visual formats) for presenting
the available evidence to such groups. In
addition, efforts are needed to build the
Box 3. Factors That May Inform Decisions about the Strength of
Recommendations Regarding Policy Options
GRADE factors (adapted from [30]):
N Whether there is uncertainty about the balance of benefits versus harms and
burdens
N The quality of the evidence from the systematic review (very low, low,
moderate, high)
N Whether there is uncertainty or variability in values and preferences among
stakeholders
N Whether there is uncertainty about whether the net benefits are worth the
costs or about resource use
N Whether there is uncertainty about the feasibility of the intervention (or about
local factors that influence the translation of evidence into practice, including
equity issues)
Additional factors that it may be useful to consider for health systems interventions:
N Ease of implementation at the systems level, including governance arrange-
ments (e.g., changes needed in regulations), financial arrangements (e.g., the
extent to which the options fit with financing models within settings), and
implementation strategies (e.g., how to provide the skills and experience
needed among implementers or facilitators)
N Socio-political considerations, e.g., how the proposed options relate to existing
policies, values within the political system in relation to issues such as equity or
privatisation, and economic changes
PLoS Medicine | www.plosmedicine.org 5 March 2012 | Volume 9 | Issue 3 | e1001187capacity of policy makers to use evidence
to inform their decisions [2,12,40].
Conclusions
Useful tools are available for grading
quality of evidence and strength of recom-
mendations on policy options regarding
health systems interventions, but several
challenges need to be addressed. Firstly,
these tools involve judgements, and these
need to be made systematically and
transparently. Secondly, for many health
systems questions, evidence is still likely to
be of low quality. Better quality research in
these areas is needed and would allow
guidance panels to have more confidence
in the evidence and to issue stronger
recommendations. Thirdly, research is
needed on ways to develop, structure,
and present policy options for consider-
ation within global health systems guid-
ance. These options need to include
evidence on health and political system
factors and implementation consider-
ations, and tools to assess such evidence
need to be refined. Finally, greater atten-
tion needs to be given to how guidance on
health systems interventions may be im-
plemented at the local level.
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Table 2. Example of factors affecting decisions about strength of recommendations—Lay or community health workers to reduce
childhood mortality.
Population: Children in high mortality settings
Intervention: Lay health workers (LHWs) delivering health promotion, treatment, and referral interventions
Comparison: No LHW intervention / usual care
Outcome: Childhood mortality
Key factors—is there
uncertainty regarding:
Decision regarding whether
there is uncertainty (yes / no) Explanation of the decision made
Quality of evidence Yes The use of LHWs in maternal and child health
programmes may lead to fewer deaths among children
under five (low quality evidence—GRADE). In addition,
the use of LHWs probably leads to an increase in the
number of women who breastfeed and to the number of
children who have their immunisation schedule up to
date (moderate quality evidence for both outcomes—
GRADE). These additional outcomes are also related to
mortality reduction
Balance of benefits versus harms and burdens Yes Potentially important benefits (mortality reduction) but
confidence interval also includes harm. Additional
evidence on LHWs suggests effectiveness, e.g., LHWs
associated with increased uptake of interventions of
proven cost-effectiveness (immunisation, breastfeeding)
Acceptability Yes N Some evidence that LHWs acceptable to service users
and used widely
N Varied acceptability to other services providers in
different settings (e.g., [43,44])
Resource use Yes Potentially large investment needed over long period
but alternatives likely to be more costly
Feasibility (or local factors that influence the
translation of evidence into practice)
Yes There may be constraints to scaling up trained LHWs and
supporting them, but it is even less feasible to scale up
professional cadres. There are a number of well-
documented examples of LHW programmes that have been
taken to scale for which monitoring has suggested some
positive outcomes, e.g., in Ethiopia and Pakistan [45,46]
Recommended options for consideration
This assessment of evidence within a wider health system context might result in the following recommended options for consideration:
N Option 1: Where child mortality is high; an infrastructure for LHWs can be developed rapidly; it is unlikely that the numbers of other cadres could be expanded; and
this cadre is acceptable to other providers and to service users and has strong political support:
# Strong recommendation to implement LHWs to reduce childhood mortality (i.e., there is confidence that the desirable effects of LHWs delivering interventions to
reduce childhood mortality outweigh the undesirable effects).
N Option 2: Where child mortality is high; LHWs are acceptable to other providers and to service users; but governance and financing mechanisms for LHWs will need
to be established, and there is little experience of running such programmes and uncertainty among policy makers:
# Conditional recommendation to implement LHWs to reduce childhood mortality (i.e., the desirable effects of LHWs delivering interventions to reduce childhood
mortality probably outweigh the undesirable effects, but there is uncertainty).
N Option 3: Where child mortality is moderate; an infrastructure for LHWs can be developed rapidly; but there is evidence that the scaling up of LHWs may be
challenged by health care professionals:
# Conditional recommendation to implement LHWs to reduce childhood mortality, dependent on the ability to overcome professional opposition (i.e., the
desirable effects of LHWs delivering interventions to reduce childhood mortality probably outweigh the undesirable effects, but there is uncertainty).
Source: This table draws on evidence from [47].
doi:10.1371/journal.pmed.1001187.t002
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